Journal of the American Academy of Dermatology · 2024
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alhusayen Raed, Dienes Serena, Lam Megan, Alavi Afsaneh, Alikhan Ali, Aleshin Maria, Bahashwan Emad, Daveluy Steve, Goldfarb Noah, Garg Amit, Gulliver Wayne, Jaleel Tarannum, Kimball Alexa B, Kirchhof Mark G, Kirby Joslyn, Lenczowski Joi, Lev-Tov Hadar, Lowes Michelle A, Lara-Corrales Irene, Micheletti Robert, Okun Martin, Orenstein Lauren, Poelman Susan, Piguet Vincent, Porter Martina, Resnik Barry, Sibbald Cathryn, Shi Vivian, Sayed Christopher, Wong Se Mang, Zaenglein Andrea, Veillette Helene, Hsiao Jennifer L, Naik Haley B
Аннотация
BACKGROUND: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.
OBJECTIVE: To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease.
METHODS: Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.
RESULTS: One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.
OBJECTIVE: To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease.
METHODS: Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process.
RESULTS: One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.